Abstract:Abstract Background DNA microarrays are rapidly becoming a fundamental tool in discovery-based genomic and biomedical research. However, the reliability of the microarray results is being challenged due to the existence of different technologies and non-standard methods of data analysis and interpretation. In the absence of a "gold standard"/"reference method" for the gene expression measurements, studies evaluating and comparing the performance of various microarray platforms have often yielded subjective and conflicting conclusions. To address this issue we have conducted a large scale TaqMan ® Gene Expression Assay based real-time PCR experiment and used this data set as the reference to evaluate the performance of two representative commercial microarray platforms. Results In this study, we analyzed the gene expression profiles of three human tissues: brain, lung, liver and one universal human reference sample (UHR) using two representative commercial long-oligonucleotide microarray platforms: (1) Applied Biosystems Human Genome Survey Microarrays (based on single-color detection); (2) Agilent Whole Human Genome Oligo Microarrays (based on two-color detection). 1,375 genes represented by both microarray platforms and spanning a wide dynamic range in gene expression levels, were selected for TaqMan ® Gene Expression Assay based real-time PCR validation. For each platform, four technical replicates were performed on the same total RNA samples according to each manufacturer's standard protocols. For Agilent arrays, comparative hybridization was performed using incorporation of Cy5 for brain/lung/liver RNA and Cy3 for UHR RNA (common reference). Using the TaqMan ® Gene Expression Assay based real-time PCR data set as the reference set, the performance of the two microarray platforms was evaluated focusing on the following criteria: (1) Sensitivity and accuracy in detection of expression; (2) Fold change correlation with real-time PCR data in pair-wise tissues as well as in gene expression profiles determined across all tissues; (3) Sensitivity and accuracy in detection of differential expression. Conclusion Our study provides one of the largest "reference" data set of gene expression measurements using TaqMan ® Gene Expression Assay based real-time PCR technology. This data set allowed us to use an alternative gene expression technology to evaluate the performance of different microarray platforms. We conclude that microarrays are indeed invaluable discovery tools with acceptable reliability for genome-wide gene expression screening, though validation of putative changes in gene expression remains advisable. Our study also characterizes the limitations of microarrays; understanding these limitations will enable researchers to more effectively evaluate microarray results in a more cautious and appropriate manner.

Effects of the Treatments of the Repeat Measurements on the Selection of Differential Expression Genes in Cdna Microarrays

Selecting Reliable Mrna Expression Measurements Across Platforms Improves Downstream Analysis

Analysis of measurement consistency of replicate probes in cDNA microarrays

A two-step strategy for detecting differential gene expression in cDNA microarray data

Evaluation of cDNA microarray data by multiple clones mapping to the same transcript.

Analysis of Reliability for Cdna Microarray Technology in Identifying Differentially Expressed Genes

[Validation of Cdna Microarray Technology].

Comparison of Methods Used for Detecting Differentially Expressed Genes

A comparison: Three analysis methods for identifying differentially expressed genes

Effects of Replacing the Unreliable Cdna Microarray Measurements on the Disease Classification Based on Gene Expression Profiles and Functional Modules.

Hotelling's T2 multivariate profiling for detecting differential expression in microarrays

The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies

Identifying differentially expressed genes in human acute leukemia and mouse brain microarray datasets utilizing QTModel

Cross-platform comparison of SYBR ® Green real-time PCR with TaqMan PCR, microarrays and other gene expression measurement technologies evaluated in the MicroArray Quality Control (MAQC) study

Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays

TaqMan Low Density Array is Roughly Right for Gene Expression Quantification in Colorectal Cancer.

Systematic Comparison of the Fidelity of Arna, Mrna and T-RNA on Gene Expression Profiling Using Cdna Microarray

The Methods of Identifying Differences in mRNA Expression

Investigation of reproducibility of differentially expressed genes in DNA microarrays through statistical simulation

Analysis on Cdna Microarry Experimental Designs

Methods for evaluating gene expression from Affymetrix microarray datasets